Lung Cancer Treatment in Shanghai
Shanghai thoracic surgery units are among the busiest in the world for lung cancer. Patients benefit from single-port VATS and robotic lobectomy with low complication rates, plus full access to molecular testing, targeted therapy (EGFR/ALK/ROS1) and immunotherapy — often approved and available faster than in many Western countries.
Common Symptoms
- Persistent cough that worsens or does not go away
- Coughing up blood (hemoptysis)
- Chest pain, especially with deep breathing or coughing
- Shortness of breath or wheezing
- Hoarseness that lasts more than two weeks
- Recurrent pneumonia or bronchitis in the same spot
Treatment Options in Shanghai
- Single-port VATS and robotic (da Vinci) lobectomy / segmentectomy
- Stereotactic body radiotherapy (SBRT) for early-stage disease
- EGFR / ALK / ROS1 targeted therapy with rapid genomic testing
- Immunotherapy (PD-1/PD-L1) as monotherapy or combined with chemo
- CT-guided biopsy and electromagnetic navigation bronchoscopy
Why Choose Shanghai
- Very high surgical volume: thousands of lung resections per year across partner centers
- Fast genomic sequencing (7-10 days) guiding targeted therapy choice
- International medical departments at Shanghai Chest Hospital, Zhongshan, Ruijin
- Comprehensive care from biopsy to rehab with a dedicated case manager
- Costs 50-70% below the US/Europe; no months-long waiting lists
Treatment Cost in Shanghai
Early-stage VATS lobectomy packages in Shanghai generally range ¥80,000–180,000 (≈$11,000–25,000). Genomic testing and targeted therapy are quoted separately after biopsy and panel results.
Partner Hospitals
- Shanghai Chest Hospital
- Fudan University Shanghai Cancer Center
- Zhongshan Hospital
- Shanghai Pulmonary Hospital
Frequently Asked Questions
Do I need surgery if my lung cancer is stage I?
For stage I disease, surgical resection (VATS/robotic) remains the standard curative option in Shanghai; SBRT is an alternative for patients unsuitable for surgery.
How fast is genetic testing for targeted therapy?
Next-generation sequencing (NGS) panels are typically completed within 7-10 days, and targeted therapy can start immediately after results are reviewed by the MDT.
Start Your Free Pre-Assessment
Send your medical records and receive a hospital match, treatment plan and transparent cost estimate within 1-2 working days.